Journal Article Cites HemoVoid™ in Etiology Study of Cancer-related Anemia

By: Biotech Support Group
 
 
Spread the Word
Listed Under

Tag:
Cancer-related Anemia

Industry:
Biotech

Location:
Monmouth Junction - New Jersey - US

Subject:
Reports

MONMOUTH JUNCTION, N.J. - Feb. 15, 2020 - PRLog -- Biotech Support Group reports on a recent research article describing the simplicity and efficiency of their hemoglobin depletion technology for enriching the red cell proteome, in order to measure autoantibodies to band 3 protein in cancer patient erythrocytes.

The citation is:

Kitao, Akihito, et al. "Band 3 ectopic expression in colorectal cancer induces an increase in erythrocyte membrane-bound IgG and may cause immune-related anemia (https://link.springer.com/article/10.1007/s12185-020-02831-y)." International Journal of Hematology (2020): 1-10.

Autoimmune hemolytic anemia (AIHA) is a rare comorbidity in colorectal cancer (CRC) and has an unknown etiology. To better understand cancer-related anemia, the authors' investigated ectopic band 3 expression and erythrocyte membrane-bound IgG in a CRC cohort. To reduce the interference from Hemoglobin, the article states "Erythrocytes were lysed … and hemoglobin was depleted using HemoVoid (Biotech Support Group, NJ, USA, Cat. No. HVK-10)". The investigation concluded that anti-band 3 antibody was higher in the IgG fraction of CRC patients' compared to that of healthy controls, and that red cell membrane-bound IgG in patients with CRC, may be clinically associated to cancer-related anemia.

Whole Blood Compartments

"Through more efficient methods to measure the various blood components– red cells, white cells, platelets and plasma, we hope our products will contribute to understanding how these compartments cross-communicate. Those connections all play a role in normal homeostasis and in disease. This article illustrates how red cells react to IgG, and how this interaction plays a role in cancer-related anemia. For this purpose, I am pleased to see that our product HemoVoid™ was a necessary and efficient step to remove interferences from Hemoglobin in the Western blot analysis", states Swapan Roy, Ph.D., President and Founder of Biotech Support Group.

For more information on HemoVoid™, visit:

http://www.biotechsupportgroup.com/HemoVoid-Hemoglobin-Depletion-From-Erythrocytes-p/hvk.htm

For more information of all of our Hemoglobin removal products, visit:

https://www.biotechsupportgroup.com/Articles.asp?ID=452

About Biotech Support Group LLC

Converging with cultural and technological disruptions forthcoming in healthcare, Biotech Support Group develops methods for cost effective and efficient sample prep essential for these expanding markets. Following a tiered business strategy, the company continues its growth in the consumable research products area supporting the rapidly expanding installation of LC-MS instrument and computational infrastructure. From these innovations, the company has acquired knowledgebase and biomarker intellectual property assets that support discoveries of protein markers from blood, with special emphasis on early detection and personalized medical decisions for cancer patients. For more information, go to http://www.biotechsupportgroup.com (http://www.biotechsupportgroup.com/biotechsupportgroup.com)

Contact:

Matthew Kuruc 732-274-2866, mkuruc@biotechsupportgroup.com

Contact
Biotech Support Group LLC
***@biotechsupportgroup.com
End
Email:***@biotechsupportgroup.com Email Verified
Tags:Cancer-related Anemia
Industry:Biotech
Location:Monmouth Junction - New Jersey - United States
Subject:Reports
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Biotech Support Group LLC PRs
Trending News
Most Viewed
Top Daily News



Like PRLog?
9K2K1K
Click to Share